5247422022-10-012023-03-315247422023-03-315247422022-10-012023-03-31RelatedPartyTransactionDomain15247422022-09-30RelatedPartyTransactionDomain15247422023-03-31RelatedPartyTransactionDomain15247422022-10-012023-03-31RelatedPartyTransactionDomain25247422022-09-30RelatedPartyTransactionDomain25247422023-03-31RelatedPartyTransactionDomain25247422022-10-012023-03-31RelatedPartyTransactionDomain35247422022-09-30RelatedPartyTransactionDomain35247422023-03-31RelatedPartyTransactionDomain35247422022-10-012023-03-31RelatedPartyTransactionDomain45247422022-09-30RelatedPartyTransactionDomain45247422023-03-31RelatedPartyTransactionDomain45247422022-10-012023-03-31RelatedPartyTransactionDomain55247422022-09-30RelatedPartyTransactionDomain55247422023-03-31RelatedPartyTransactionDomain55247422022-10-012023-03-31RelatedPartyTransactionDomain65247422022-09-30RelatedPartyTransactionDomain65247422023-03-31RelatedPartyTransactionDomain65247422022-10-012023-03-31RelatedPartyTransactionDomain75247422022-09-30RelatedPartyTransactionDomain75247422023-03-31RelatedPartyTransactionDomain75247422022-10-012023-03-31RelatedPartyTransactionDomain85247422022-09-30RelatedPartyTransactionDomain85247422023-03-31RelatedPartyTransactionDomain85247422022-10-012023-03-31RelatedPartyTransactionDomain95247422022-09-30RelatedPartyTransactionDomain95247422023-03-31RelatedPartyTransactionDomain95247422022-10-012023-03-31RelatedPartyTransactionDomain105247422022-09-30RelatedPartyTransactionDomain105247422023-03-31RelatedPartyTransactionDomain105247422022-10-012023-03-31RelatedPartyTransactionDomain115247422022-09-30RelatedPartyTransactionDomain115247422023-03-31RelatedPartyTransactionDomain115247422022-10-012023-03-31RelatedPartyTransactionDomain125247422022-09-30RelatedPartyTransactionDomain125247422023-03-31RelatedPartyTransactionDomain125247422022-10-012023-03-31RelatedPartyTransactionDomain135247422022-09-30RelatedPartyTransactionDomain135247422023-03-31RelatedPartyTransactionDomain135247422022-10-012023-03-31RelatedPartyTransactionDomain145247422022-09-30RelatedPartyTransactionDomain145247422023-03-31RelatedPartyTransactionDomain145247422022-10-012023-03-31RelatedPartyTransactionDomain155247422022-09-30RelatedPartyTransactionDomain155247422023-03-31RelatedPartyTransactionDomain155247422022-10-012023-03-31RelatedPartyTransactionDomain165247422022-09-30RelatedPartyTransactionDomain165247422023-03-31RelatedPartyTransactionDomain165247422022-10-012023-03-31RelatedPartyTransactionDomain175247422022-09-30RelatedPartyTransactionDomain175247422023-03-31RelatedPartyTransactionDomain175247422022-10-012023-03-31RelatedPartyTransactionDomain185247422022-09-30RelatedPartyTransactionDomain185247422023-03-31RelatedPartyTransactionDomain185247422022-10-012023-03-31RelatedPartyTransactionDomain195247422022-09-30RelatedPartyTransactionDomain195247422023-03-31RelatedPartyTransactionDomain195247422022-10-012023-03-31RelatedPartyTransactionDomain205247422022-09-30RelatedPartyTransactionDomain205247422023-03-31RelatedPartyTransactionDomain205247422022-10-012023-03-31RelatedPartyTransactionDomain215247422022-09-30RelatedPartyTransactionDomain215247422023-03-31RelatedPartyTransactionDomain215247422022-10-012023-03-31RelatedPartyTransactionDomain225247422022-09-30RelatedPartyTransactionDomain225247422023-03-31RelatedPartyTransactionDomain225247422022-10-012023-03-31RelatedPartyTransactionDomain235247422022-09-30RelatedPartyTransactionDomain235247422023-03-31RelatedPartyTransactionDomain235247422022-10-012023-03-31RelatedPartyTransactionDomain245247422022-09-30RelatedPartyTransactionDomain245247422023-03-31RelatedPartyTransactionDomain245247422022-10-012023-03-31RelatedPartyTransactionDomain255247422022-09-30RelatedPartyTransactionDomain255247422023-03-31RelatedPartyTransactionDomain255247422022-10-012023-03-31RelatedPartyTransactionDomain265247422022-09-30RelatedPartyTransactionDomain265247422023-03-31RelatedPartyTransactionDomain265247422022-10-012023-03-31RelatedPartyTransactionDomain275247422022-09-30RelatedPartyTransactionDomain275247422023-03-31RelatedPartyTransactionDomain275247422022-10-012023-03-31RelatedPartyTransactionDomain285247422022-09-30RelatedPartyTransactionDomain285247422023-03-31RelatedPartyTransactionDomain285247422022-10-012023-03-31RelatedPartyTransactionDomain295247422022-09-30RelatedPartyTransactionDomain295247422023-03-31RelatedPartyTransactionDomain295247422022-10-012023-03-31RelatedPartyTransactionDomain305247422022-09-30RelatedPartyTransactionDomain305247422023-03-31RelatedPartyTransactionDomain305247422022-10-012023-03-31RelatedPartyTransactionDomain315247422022-09-30RelatedPartyTransactionDomain315247422023-03-31RelatedPartyTransactionDomain315247422022-10-012023-03-31RelatedPartyTransactionDomain325247422022-09-30RelatedPartyTransactionDomain325247422023-03-31RelatedPartyTransactionDomain325247422022-10-012023-03-31RelatedPartyTransactionDomain335247422022-09-30RelatedPartyTransactionDomain335247422023-03-31RelatedPartyTransactionDomain335247422022-10-012023-03-31RelatedPartyTransactionDomain345247422022-09-30RelatedPartyTransactionDomain345247422023-03-31RelatedPartyTransactionDomain345247422022-10-012023-03-31RelatedPartyTransactionDomain355247422022-09-30RelatedPartyTransactionDomain355247422023-03-31RelatedPartyTransactionDomain355247422022-10-012023-03-31RelatedPartyTransactionDomain365247422022-09-30RelatedPartyTransactionDomain365247422023-03-31RelatedPartyTransactionDomain365247422022-10-012023-03-31RelatedPartyTransactionDomain375247422022-09-30RelatedPartyTransactionDomain375247422023-03-31RelatedPartyTransactionDomain375247422022-10-012023-03-31RelatedPartyTransactionDomain385247422022-09-30RelatedPartyTransactionDomain385247422023-03-31RelatedPartyTransactionDomain385247422022-10-012023-03-31RelatedPartyTransactionDomain395247422022-09-30RelatedPartyTransactionDomain395247422023-03-31RelatedPartyTransactionDomain395247422022-10-012023-03-31RelatedPartyTransactionDomain405247422022-09-30RelatedPartyTransactionDomain405247422023-03-31RelatedPartyTransactionDomain405247422022-10-012023-03-31RelatedPartyTransactionDomain415247422022-09-30RelatedPartyTransactionDomain415247422023-03-31RelatedPartyTransactionDomain415247422022-10-012023-03-31RelatedPartyTransactionDomain425247422022-09-30RelatedPartyTransactionDomain425247422023-03-31RelatedPartyTransactionDomain425247422022-10-012023-03-31RelatedPartyTransactionDomain435247422022-09-30RelatedPartyTransactionDomain435247422023-03-31RelatedPartyTransactionDomain435247422022-10-012023-03-31RelatedPartyTransactionDomain445247422022-09-30RelatedPartyTransactionDomain445247422023-03-31RelatedPartyTransactionDomain445247422022-10-012023-03-31RelatedPartyTransactionDomain455247422022-09-30RelatedPartyTransactionDomain455247422023-03-31RelatedPartyTransactionDomain455247422022-10-012023-03-31RelatedPartyTransactionDomain465247422022-09-30RelatedPartyTransactionDomain465247422023-03-31RelatedPartyTransactionDomain465247422022-10-012023-03-31RelatedPartyTransactionDomain475247422022-09-30RelatedPartyTransactionDomain475247422023-03-31RelatedPartyTransactionDomain475247422022-10-012023-03-31RelatedPartyTransactionDomain485247422022-09-30RelatedPartyTransactionDomain485247422023-03-31RelatedPartyTransactionDomain485247422022-10-012023-03-31RelatedPartyTransactionDomain495247422022-09-30RelatedPartyTransactionDomain495247422023-03-31RelatedPartyTransactionDomain495247422022-10-012023-03-31RelatedPartyTransactionDomain505247422022-09-30RelatedPartyTransactionDomain505247422023-03-31RelatedPartyTransactionDomain505247422022-10-012023-03-31RelatedPartyTransactionDomain515247422022-09-30RelatedPartyTransactionDomain515247422023-03-31RelatedPartyTransactionDomain515247422022-10-012023-03-31RelatedPartyTransactionDomain525247422022-09-30RelatedPartyTransactionDomain525247422023-03-31RelatedPartyTransactionDomain525247422022-10-012023-03-31RelatedPartyTransactionDomain535247422022-09-30RelatedPartyTransactionDomain535247422023-03-31RelatedPartyTransactionDomain535247422022-10-012023-03-31RelatedPartyTransactionDomain545247422022-09-30RelatedPartyTransactionDomain545247422023-03-31RelatedPartyTransactionDomain545247422022-10-012023-03-31RelatedPartyTransactionDomain555247422022-09-30RelatedPartyTransactionDomain555247422023-03-31RelatedPartyTransactionDomain555247422022-10-012023-03-31RelatedPartyTransactionDomain565247422022-09-30RelatedPartyTransactionDomain565247422023-03-31RelatedPartyTransactionDomain565247422022-10-012023-03-31RelatedPartyTransactionDomain575247422022-09-30RelatedPartyTransactionDomain575247422023-03-31RelatedPartyTransactionDomain57iso4217:INRxbrli:pureCAPLIN POINT LABORATORIES LIMITED524742CAPLIPOINTNOTLISTED2022-04-012023-03-31Second half yearly2022-10-012023-03-31CrorestruetrueNANAfalsefalseCaplin Point Laboratories LimitedDrogueria Saimed De HondurasWholly owned step down SubsidiarySale of goods or services1500000000Not Applicable1132200000-185900000Caplin Point Laboratories LimitedNuevos Eticos NeoethicalsStep Down SubsidiarySale of goods or services2500000000Not Applicable468100000-29800000273200000Caplin Point Laboratories LimitedNeo Ethicals CIAWholly owned step down SubsidiarySale of goods or services1500000000Not Applicable32279000054000000240000000Caplin Point Laboratories LimitedNeo Ethicals SAWholly owned step down SubsidiarySale of goods or services1500000000Not Applicable11606000013200000-48400000Caplin Point Laboratories LimitedAshvich Infotek Private LimitedDirector's relatives are interestedAny other transactionRent & Consultancy100000000Not Applicable6090000-400000-400000Caplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiaryPurchase of goods or services12500000Not Applicable185000000Caplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiaryPurchase of fixed assets12500000Not Applicable10000000Caplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiaryAny other transactionAvailing of services & Corporate Office common expenses recovery25000000Not Applicable292000000Caplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiaryAny other transactionSale of Assets and Materials12500000Not Applicable81000000Caplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiaryAny other transactionCapex Services recovery25000000Not Applicable425000000Caplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiaryLoan4250000000Not Applicable9200000006400000001560000000Loan0.09410 years (5 yrs moratorium + 5 years repayment)UnsecuredFor Capex Project<DIV > <DIV>Interest rate is State Bank of India’s Marginal Cost of Fund based Lending Rate (MCLR) + 2% Spread</DIV></DIV>Caplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiaryInterest received73600000Not Applicable7360000000Caplin Point Laboratories LimitedDr. Sridhar GanesanKey Managerial PersonnelRemuneration0Not Applicable277000000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV></DIV></DIV>Caplin Point Laboratories LimitedDr. Sridhar GanesanKey Managerial PersonnelAny other transactionEquity Shares pursuant to employees stock option scheme0Not Applicable300000000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV></DIV></DIV>Caplin Point Laboratories LimitedMr. Muralidharan DKey Managerial PersonnelRemuneration0Not Applicable190000000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV></DIV></DIV>Caplin Point Laboratories LimitedMr. Muralidharan DKey Managerial PersonnelAny other transactionEquity Shares pursuant to employees stock option scheme0Not Applicable285000000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV></DIV></DIV>Caplin Point Laboratories LimitedMr. Partheeban Vivek SiddarthChief Operating OfficerRemuneration0Not Applicable102000000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV></DIV></DIV>Caplin Point Laboratories LimitedMr. Venkatram GKey Managerial PersonnelRemuneration0Not Applicable170000000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV></DIV></DIV>Caplin Point Laboratories LimitedMr. D SathyanarayananIndependent DirectorAny other transactionSitting Fees0Not Applicable10000000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV></DIV></DIV>Caplin Point Laboratories LimitedMr. V ThirumalaiIndependent DirectorAny other transactionSitting Fees0Not Applicable6000000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV></DIV></DIV>Caplin Point Laboratories LimitedMr. R ViswanathanIndependent DirectorAny other transactionSitting Fees0Not Applicable10000000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV></DIV></DIV>Caplin Point Laboratories LimitedDr. C K GariyaliIndependent DirectorAny other transactionSitting Fees0Not Applicable4000000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV></DIV></DIV>Caplin Point Laboratories LimitedMr. S DeenadayalanIndependent DirectorAny other transactionSitting Fees0Not Applicable6000000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV></DIV></DIV>Caplin Point Laboratories LimitedDr R NagendranIndependent DirectorAny other transactionSitting Fees0Not Applicable4000000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV></DIV></DIV>Caplin Point Laboratories LimitedCaplin Onco Limitedwholly owned SubsidiaryAny other transactionRent received from COL0Not Applicable108000000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee - NA as the counter party is Wholly owned Subsidiary of the listed entity</DIV> <DIV></DIV></DIV>Caplin Point Laboratories LimitedCaplin Onco Limitedwholly owned SubsidiaryInvestment0Not Applicable190000000470000000660000000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee - NA as the counter party is Wholly owned Subsidiary of the listed entity</DIV></DIV></DIV>Caplin Point Laboratories LimitedArgus Salud Pharma LLPSubsidiaryAny other transactionShare of profit from the LLP10000000Not Applicable630000500000600000Caplin Point Laboratories LimitedCaplin Point Far East Limited, (Hong Kong)Wholly owned SubsidiaryAny other transactionSale of investment0Not Applicable23200000288000000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee - NA as the counter party is Wholly owned Subsidiary of the listed entity</DIV></DIV></DIV>Caplin Steriles LimitedMr. M SathyanarayanKey Managerial PersonnelRemuneration0Not Applicable330000000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV></DIV></DIV>Caplin Steriles LimitedMr. M SathyanarayanKey Managerial PersonnelAny other transactionEquity Shares pursuant to employees stock option scheme0Not Applicable290000000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV></DIV></DIV>Caplin Steriles LimitedAshvich Infotek Private LimitedDirector and Director's relatives are interestedAny other transactionRent & Consultancy20000000Not Applicable750000000Caplin Steriles LimitedSunsole Solar Private LimitedAssociate CompanyPurchase of goods or services0Not Applicable596000000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee&nbsp; - NA as the transaction does not cross the threshold as specified under reg 23(2b)</DIV> <DIV></DIV></DIV>Caplin Steriles LimitedCaplin Onco LimitedFellow subsidaryPurchase of fixed assets0Not Applicable2402000000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee&nbsp; - NA as the transaction does not cross the threshold as specified under reg 23(2b)</DIV></DIV>Caplin Point Far East Limited, (Hong Kong)Caplin Point laboratories Colombia, SAS, (Colombia)Fellow subsidaryInvestment0Not Applicable27300000027300000<DIV > <DIV></DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee&nbsp; - NA as the transaction does not cross the threshold as specified under reg 23(2b)</DIV></DIV>Caplin Point Far East Limited, (Hong Kong)Caplin point Singapore (PTE) LtdFellow subsidaryPurchase of goods or services0Not Applicable4800000500000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee&nbsp; - NA as the transaction is between two Wholly - Owned Subsidaries</DIV></DIV></DIV>Caplin Point Far East Limited, (Hong Kong)Drogueria Saimed De HondurasWholly owned Subsidiary CompanySale of goods or services0Not Applicable234600000938100000966100000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee&nbsp; - NA as the transaction is between two Wholly Owned Subsidaries </DIV></DIV></DIV>Caplin Point Far East Limited, (Hong Kong)Nuevos Eticos NeoethicalsSubsidiarySale of goods or services750000000Not Applicable330300000712800000943200000Caplin Point Far East Limited, (Hong Kong)Neo Ethicals CIAWholly owned Subsidiary CompanySale of goods or services0Not Applicable47300000491600000457900000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee&nbsp; - NA as the transaction is between two Wholly Owned Subsidaries </DIV></DIV></DIV>Caplin Point Far East Limited, (Hong Kong)Neo Ethicals SAWholly owned Subsidiary CompanySale of goods or services0Not Applicable-2900000361100000409400000<DIV > <DIV></DIV> <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee&nbsp; - NA as the transaction is between two Wholly Owned Subsidaries </DIV></DIV></DIV>Caplin Point Far East Limited, (Hong Kong)Caplin Point EL salvador S.A De C.V.Wholly owned Subsidiary CompanySale of goods or services0Not Applicable0-171200000-172600000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee&nbsp; - NA as the transaction is between two Wholly Owned Subsidaries </DIV></DIV></DIV>Caplin Onco LimitedAshvich Infotek Private LimitedDirector’s relatives are interestedAny other transactionRent paid by COL0Not Applicable5000000<DIV > <DIV></DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee&nbsp; - NA as the transaction does not cross the threshold as specified under reg 23(2b)</DIV></DIV>Argus Salud Pharma LLPMay India Property Private LimitedPatners/directors are interestedAny other transactionShare of profit from the LLP0Not Applicable000<DIV > <DIV></DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee&nbsp; - NA as the transaction does not cross the threshold as specified under reg 23(2b)</DIV></DIV>Nuevos Eticos Neoethicals S.A GuatemalaCaplin Point laboratories Colombia, SAS, (Colombia)Fellow subsidariesAny other transactionTrade Payables0Not Applicable10000024500002470000<DIV > <DIV> <DIV> <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee&nbsp; - NA as the transaction does not cross the threshold as specified under reg 23(2b)</DIV></DIV></DIV></DIV></DIV>Neo Ethicals CIA LTDA EcuadorDrogueria Saimed De HondurasFellow subsidariesSale of goods or services0Not Applicable015700001430000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee -NA as the transaction is between two Wholly Owned Subsidiaries.</DIV></DIV></DIV>Caplin Point El Salvador, S.A. DE C.VNeo Ethicals SA NicaraguaFellow subsidariesPurchase of goods or services0Not Applicable018000000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee -NA as the transaction is between two Wholly Owned Subsidiaries</DIV></DIV></DIV>Nuevos Eticos Neoethicals S.A GuatemalaDrogueria Saimed De HondurasFellow subsidariesSale of goods or services0Not Applicable34400002449000027930000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee -NA as the transaction does not cross the threshold as specified under reg 23(2b)</DIV></DIV></DIV>Nuevos Eticos Neoethicals S.A GuatemalaNeo Ethicals SA NicaraguaFellow subsidariesSale of goods or services0Not Applicable6000003640000037010000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee -NA as the transaction does not cross the threshold as specified under reg 23(2b)</DIV></DIV></DIV>Nuevos Eticos Neoethicals S.A GuatemalaNeo Ethicals CIA LTDAFellow subsidariesSale of goods or services0Not Applicable16410000319000019600000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee -NA as the transaction does not cross the threshold as specified under reg 23(2b)</DIV> <DIV></DIV></DIV>Nuevos Eticos Neoethicals S.A GuatemalaDrogueria Saimed De HondurasFellow subsidariesPurchase of goods or services0Not Applicable733000013300008660000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee -NA as the transaction does not cross the threshold as specified under reg 23(2b)</DIV></DIV></DIV>Nuevos Eticos Neoethicals S.A GuatemalaNeo Ethicals SA NicaraguaFellow subsidariesPurchase of goods or services0Not Applicable02057000011410000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee -NA as the transaction does not cross the threshold as specified under reg 23(2b)</DIV></DIV></DIV>Nuevos Eticos Neoethicals S.A GuatemalaNeo Ethicals CIA LTDAFellow subsidariesPurchase of goods or services0Not Applicable14290000615000020440000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee -NA as the transaction does not cross the threshold as specified under reg 23(2b)</DIV></DIV></DIV>Drogueria Saimed De HondurasNeo Ethicals SA NicaraguaFellow subsidariesPurchase of goods or services0Not Applicable10000490000500000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee -NA as the transaction is between two Wholly Owned Subsidiaries</DIV></DIV></DIV>Drogueria Saimed De HondurasNeo Ethicals SA NicaraguaFellow subsidariesSale of goods or services0Not Applicable2000002350000023740000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee -NA as the transaction is between two Wholly Owned Subsidiaries</DIV></DIV></DIV>Neo Ethicals SA NicaraguaCaplin Point El Salvador S.A. de C.V.Fellow subsidariesPurchase of goods or services0Not Applicable017100001710000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee -NA as the transaction is between two Wholly Owned Subsidiaries</DIV></DIV>Neo Ethicals SA NicaraguaDrogueria Saimed de Honduras S.A.Fellow subsidariesPurchase of goods or services0Not Applicable16300002288000024510000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee -NA as the transaction is between two Wholly Owned Subsidiaries</DIV></DIV></DIV>Neo Ethicals SA NicaraguaNeo Ethicals CIA LTDAFellow subsidariesPurchase of goods or services0Not Applicable927000009270000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee -NA as the transaction is between two Wholly Owned Subsidiaries</DIV></DIV>Caplin Point Laboratories LimitedCaplin Onco LimitedWholly owned SubsidiaryPurchase of goods or services0Not Applicable620000000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee - NA as the counter party is Wholly owned Subsidiary of the listed entity</DIV></DIV>